Navigation Links
Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010
Date:10/15/2010

Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States... -- BOSTON, October 15, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010

 

BOSTON, October 15, 2010 /PRNewswire/ -- Attendees at this year's annual meeting of the American Society for Surgery of the Hand (ASSH) received pre-conference analysis of the advantages of Materialise's SurgiCase(R) Orthopaedics service for treating distal radius malunions. The speaker was renowned hand surgeon Dr. F. Stockmans. He's also one of the first to integrate SurgiCase(R) into his practice as a solution for patients with exceptional needs.

It's been five years since Dr. Stockmans recognized how valuable SurgiCase(R) is to hand and wrist surgeons faced with challenging surgeries: malunions, non-unions or some instances of congenital deformity. The comprehensive service, which centers on the use of CT/MRI scanned images, consists of three components: virtual surgery planning, the generation of 3D patient models, and the construction of cut and drill guides custom-fit to the patient. It gives the surgeon the capability to try multiple approaches to complicated procedures before entering the operation room. Working together, these components help the surgeon repair complex 3D deformations that would otherwise be impossible to treat using conventional 2D techniques.

Dr. Stockmans has published his successful case histories in the latest issue of Orthopreneur. About SurgiCase(R) increased visibility, he says: "After five years of preparatory studies, I'm thrilled that SurgiCase(R) Orthopaedics is finally being introduced to the surgical community. The possibility of visualizing the pathology in 3D and trying different approaches prior to going into surgery is tremendous. Individualized cut and drill guides have helped me shorten the intervention period, enabling me to treat more cases in the same amount of time. The engineers at Materialise are very professional. I feel much more confident going into the OR."

Materialise launched SurgiCase(R) Orthopaedics in the United States at the ASSH. With the development of its SurgiCase(R) cut and drill guides, Materialise will take a huge step towards putting custom tools into the hands of hand and wrist surgeons.

http://www.materialise.com/orthopaedics


'/>"/>
SOURCE Materialise
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimers Disease
2. Materialise Launches SurgiCase(R) Orthopaedics: A Comprehensive, Custom Solution That Assures Best Practices For The Orthopaedic Surgeon
3. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
6. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
7. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
8. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
9. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
11. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
Breaking Medicine News(10 mins):